Vendor, New York, NY
The Global Alliance for TB Drug Development Inc.
UEI CA1RNRESAZU6, CAGE 52VM4
1 award and $2,475,623 obligated between May 9, 2024 and August 26, 2026, 100% under full and open competition, against 18.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $2,475,623 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Hear when The Global Alliance for TB Drug Development Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts The Global Alliance for TB Drug Development Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $2,475,623
- Soonest
- April 30, 2028
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- 2023 NIAID Omnibus Broad Agency Announcement
National Institutes of Health, National Institutes of Health Niaid
Award noticeNAICS 541715New York, NYHHS-NIH-NIAID-BAA2023-1Awarded to The Global Alliance for TB Drug Development Inc. for $9,851,406
Posted May 9, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00008Definitive Contract, May 9, 2024, Full and Open Competition, 18 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | To Develop a Novel Modulator Targeting Proteostasis for the Treatment of M. Tuberculosis.NAICS 541715, PSC AN12 | $2,475,623 |
- Places of performance
- New York
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 5 across 1 awards